Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 121 AL 135

Quality of life (QoL) in community-dwelling and institutionalized Alzheimer's disease (AD) patients

León-Salas B, Olazarán J, Cruz-Orduña I, Agüera-Ortiz L, Dobato JL, Valentí-Soler M, Muñiz R, González-Salvador MT, Martínez-Martín P.

Arch Gerontol Geriatr. 2013 Nov-Dec;57(3):257-62. doi: 10.1016/j.archger.2013.04.013. Epub 2013 May 22.

Drug development in dementia

Cunningham EL, Passmore AP.

Maturitas. 2013 Nov;76(3):260-6. doi: 10.1016/j.maturitas.2013.04.013. Epub 2013 May 23.

Research progress on natural products from traditional Chinese medicine in treatment of Alzheimer's disease

Gao J, Inagaki Y, Li X, Kokudo N, Tang W.

Drug Discov Ther. 2013 Apr;7(2):46-57.

Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies

Ramachandran G, Udgaonkar JB.

Biochemistry. 2013 Jun 18;52(24):4107-26. doi: 10.1021/bi400209z. Epub 2013 Jun 6.

Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease

Igeta H, Suzuki Y, Motegi T, Sasaki A, Yokoyama Y, Someya T.

Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):680.e9-10. doi: 10.1016/j.genhosppsych.2013.04.007. Epub 2013 Jun 2.

Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease

Cornejo F, von Bernhardi R.

Mediators Inflamm. 2013;2013:895651. doi: 10.1155/2013/895651. Epub 2013 May 7.

Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia

Bahar-Fuchs A, Clare L, Woods B.

Cochrane Database Syst Rev. 2013 Jun 5;2013(6):CD003260. doi: 10.1002/14651858.CD003260.pub2.

Alzheimer's disease and frail syndrome: features overlap predictive of poor outcome

Martorana A.

CNS Neurol Disord Drug Targets. 2013 Jun;12(4):506. doi: 10.2174/18715273113129990068.

Nutritional approaches in the risk reduction and management of Alzheimer's disease

Mi W, van Wijk N, Cansev M, Sijben JW, Kamphuis PJ.

Nutrition. 2013 Sep;29(9):1080-9. doi: 10.1016/j.nut.2013.01.024. Epub 2013 Jun 4.

Evaluation of the efficacy of a cognitive rehabilitation treatment on a group of Alzheimer's patients with moderate cognitive impairment: a pilot study

Salotti P, De Sanctis B, Clementi A, Fernandez Ferreira M, De Silvestris T.

Aging Clin Exp Res. 2013 Aug;25(4):403-9. doi: 10.1007/s40520-013-0062-5. Epub 2013 Jun 13.

Spreading of tau pathology in Alzheimer's disease by cell-to-cell transmission

Mohamed NV, Herrou T, Plouffe V, Piperno N, Leclerc N.

Eur J Neurosci. 2013 Jun;37(12):1939-48. doi: 10.1111/ejn.12229.

Caspase-6 as a novel early target in the treatment of Alzheimer's disease

LeBlanc AC.

Eur J Neurosci. 2013 Jun;37(12):2005-18. doi: 10.1111/ejn.12250.

Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: comparison with memantine

Hemmati F, Dargahi L, Nasoohi S, Omidbakhsh R, Mohamed Z, Chik Z, Naidu M, Ahmadiani A.

Behav Brain Res. 2013 Sep 1;252:415-21. doi: 10.1016/j.bbr.2013.06.016. Epub 2013 Jun 15.

One-year repeated cycles of cognitive training (CT) for Alzheimer's disease

Bergamaschi S, Arcara G, Calza A, Villani D, Orgeta V, Mondini S.

Aging Clin Exp Res. 2013 Aug;25(4):421-6. doi: 10.1007/s40520-013-0065-2. Epub 2013 Jun 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias